What is Adipotide?
Adipotide (Fat Targeting Pro-apoptotic Peptide) is a synthetic chimeric peptide. It was developed at the MD Anderson Cancer Center as a novel approach to treating obesity. Unlike traditional weight-loss compounds that suppress appetite or increase metabolism, Adipotide works by physically eliminating the storage sites for fat.
It is composed of two functional parts: a homing sequence that finds fat tissue, and a "killer" sequence that triggers cell death once it arrives.
⚗️ Key Research Facts
- Sequence: CKGGRAKDC-GG-D(KLAKLAK)2
- Class: Pro-apoptotic Peptidomimetic
- Primary Goal: Selective Destruction of White Fat
- Mechanism: Vasculature Targeted Apoptosis
Mechanism: CKGGRAKDC Targeting
Adipotide's effectiveness lies in its "homing" sequence (CKGGRAKDC). This sequence is designed to bind specifically to receptors found on the **endothelial cells** (blood vessel lining) that supply white adipose tissue.
This allows the peptide to bypass healthy organs and muscles, concentrating its action specifically in the blood vessels that feed fat stores.
Inducing Fat Cell Apoptosis
Once Adipotide binds and enters the target endothelial cells, its second domain (KLAKLAK) goes to work. This domain disrupts the mitochondrial membrane of the cell, leading to Apoptosis (programmed cell death).
- Blood Supply Cutoff: The vessels feeding the fat tissue are destroyed.
- Ischemic Injury: Deprived of blood, the fat cells (adipocytes) begin to die.
- Clearance: The body's immune system then identifies the dead fat cells and clears them out naturally.
Primate Research Findings
Some of the most significant Adipotide research was conducted on obese rhesus monkeys. In these studies, subjects lost an average of 11% of their total body weight in just 28 days. More importantly, they showed a 27% reduction in abdominal fat and a significant improvement in insulin sensitivity.
Research Protocols & Kidney Safety
- Administration: Subcutaneous injection.
- Research Dose: Typically 0.43 mg/kg (in primate models).
- Renal Impact: Because the peptide is excreted through the kidneys, research often observes "renal tubular dysfunction" at higher doses. Monitoring of creatinine and kidney biomarkers is essential.
- Current Status: Strictly for laboratory and preclinical research. Not approved for human administration.
Frequently Asked Questions
Is Adipotide safer than Semaglutide?
No. While it produces very rapid fat loss, its mechanism (cell death) is much more aggressive than the metabolic signaling of GLP-1 agonists. The risk of kidney toxicity makes it a much higher-risk research subject.
Does it work on brown fat?
Research indicates Adipotide is selective for the blood vessels of **White Adipose Tissue (WAT)**. It generally spares Brown Adipose Tissue (BAT), which is beneficial as brown fat is responsible for thermogenesis (heat production).
Where to buy Adipotide in Canada?
Nūmira Peptides offers high-purity Adipotide for laboratory and scientific research across Canada. Shop Adipotide →
Adipotide — Research Grade
Purity >98% · Pro-Apoptotic Technology · Domestic Canadian shipping
Shop Adipotide →